The company plans to use proceeds from the fresh issue primarily for repayment or pre-payment of borrowings, capital expenditure at its Hyderabad facilities
The company’s Sustainability Report 2025–26 highlights progress across ESG priorities
The results support advancing both programs as it seeks to develop therapies for major unmet needs in eye care.
Robenacoxib Injection is indicated for postoperative pain and inflammation associated with soft tissue surgery in dogs
The technology combines a novel fluorescent probe, TZ-48, with a smartphone-integrated system called ADxFluor
The company said it intends to challenge the order through the appropriate appellate process
According to company’s regulatory filing, the inspection was conducted from August 17 to August 25, 2026, and concluded with the issuance of a Form 483 containing seven observations
The initial portfolio comprises products across sterile injectables, biologics and topical formulations to be manufactured at Aurigene’s facilities in India
The investment further strengthens the company’s track record of partnering with high-quality mid-market businesses and providing tailored capital solutions
The rating agency independently prepared its ESG assessment using publicly available information relating to the company
The trial is intended to generate clinical evidence for PADN in a patient population where treatment options remain limited
The move to invest in Ampin C&I Power Twelve is expected to increase the use of renewable energy and potentially lower energy costs
The new framework with PHARMEXCIL is intended to strengthen collaboration between the regulator and the pharmaceutical export industry while supporting the government's broader Ease of Doing Business agenda
The partnership represents a broader industry-academia approach to skills development in orthopaedics, with the focus on simulation-based learning and greater familiarity with emerging surgical technologies
Union minister expressed confidence that by expanding interdisciplinary collaborations, CSIR-TKDL can further strengthen the global relevance and impact of India's traditional knowledge repository
Delegate registrations are open for a high-level discussion on how genomics is transforming healthcare from reactive treatment to predictive, preventive and personalised care
The proposed pivot marks a significant expansion of company to pursue opportunities across medical devices, diagnostics, robotics, AI, digital health and healthcare infrastructure
With R&D spending reaching 8.4% of revenue, Zydus’ strategy is focused on combining its established pharma base with innovation, specialty medicines, biosimilars and new healthcare businesses
The event focused on emerging advances in medicinal chemistry, drug design, target identification, computational drug discovery and more, with discussions aimed at bridging fundamental research and clinical applications
The inspection was conducted at Lannett Company's manufacturing facility in Seymour, Indiana, USA, from August 17 to 21, 2026
Subscribe To Our Newsletter & Stay Updated
